{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:04:45Z","timestamp":1770822285172,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ygyno.2011.04.037","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T18:45:54Z","timestamp":1306349154000},"page":"291-296","source":"Crossref","is-referenced-by-count":18,"title":["Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results"],"prefix":"10.1016","volume":"122","author":[{"given":"Chengquan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangbai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Onisko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anisa","family":"Kanbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Marshall","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.04.037_bb0005","author":"US Food and Drug Administration"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Cox","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajog.2007.07.050","article-title":"2006 Consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-151-9-200911030-00005","article-title":"Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006 to 2007","volume":"151","author":"Yabroff","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jncimonographs\/lgq009","article-title":"Factors in quality care\u2014the case of follow-up to abnormal cancer screening tests\u2014problems in the steps and interfaces of care","volume":"2010","author":"Zapka","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ypmed.2005.09.010","article-title":"Primary care physicians' awareness and adherence to cervical cancer screening guidelines in Texas","volume":"42","author":"Holland-Barkis","year":"2006","journal-title":"Prev Med"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/AJCPAZV88VIFZSFD","article-title":"High risk HPV testing in women 30 years or older with negative Papanicolaou tests. Initial experience with 18 month follow-up","volume":"133","author":"Thrall","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181996ffa","article-title":"Five-year experience of human papillomavirus DNA and Papanicolaou cotesting","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2010.12.361","article-title":"Characteristics of 44 cervical cancers diagnosed following Pap negative HPV positive screening in routine clinical practice","volume":"121","author":"Kinney","year":"2011","journal-title":"Gyncol Oncol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"Datta","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0060","author":"US Census Bureau"},{"issue":"2","key":"10.1016\/j.ygyno.2011.04.037_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2007.06.025","article-title":"Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone","volume":"107","author":"Zhao","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2011.04.037_bb0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cncr.23598","article-title":"Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical\/transformation zone sample","volume":"114","author":"Zhao","year":"2008","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"10.1016\/j.ygyno.2011.04.037_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","article-title":"Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods","volume":"114","author":"Zhao","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ygyno.2011.04.037_bb0080","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.5858\/132.12.1874","article-title":"Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results","volume":"132","author":"Bandyopadhyay","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.ygyno.2011.04.037_bb0085","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.5858\/133.9.1426","article-title":"Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice","volume":"133","author":"Armah","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.ygyno.2011.04.037_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.22949","article-title":"Very low human papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests","volume":"111","author":"Zhao","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2011.04.037_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ygyno.2009.07.010","article-title":"High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older","volume":"115","author":"Bansal","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000320877","article-title":"HPV test results stratify risk for histopathologic follow-up findings of high grade cervical intraepithelial neoplasia in women with LSIL Pap results","volume":"55","author":"Heider","year":"2011","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.5858\/2009-0624-OA.1","article-title":"Significance of high risk HPV DNA detection in women 50 and older with squamous cell Pap test abnormalities","volume":"134","author":"Zhao","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"7609","key":"10.1016\/j.ygyno.2011.04.037_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.39219.645475.55","article-title":"Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study","volume":"335","author":"Davey","year":"2007","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.ygyno.2011.04.037_bb0115","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1128\/JCM.41.9.4022-4030.2003","article-title":"Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer","volume":"41","author":"Castle","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0125","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"377","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0130","series-title":"Cervical Cytology Screening. Number 109","article-title":"Clinical management guidelines for obstetrician\u2013gynecologists","author":"Practice Bulletin","year":"2009"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","article-title":"Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis","volume":"95","author":"Sherman","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0140","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","article-title":"A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women","volume":"94","author":"Castle","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0145","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/cncr.10927","article-title":"Absolute risk of subsequent abnormal Pap among oncogenic human papillomavirus DNA-positive cytologically negative women","volume":"95","author":"Castle","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","article-title":"Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis","volume":"95","author":"Sherman","year":"2003","journal-title":"JNCI"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0155","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0160","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.262.7.931","article-title":"The 1988 Bethesda System for reporting cervical\/vaginal cytologic diagnoses","volume":"262","author":"National Cancer Institute Workshop","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-9378-4-7","article-title":"The evolving definition of carcinogenic Human Papillomavirus","volume":"4","author":"Castle","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0170","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S1386-6532(02)00187-7","article-title":"Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail","volume":"25","author":"Poljak","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ygyno.2006.10.048","article-title":"Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples","volume":"104","author":"Cibas","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AOG.0b013e3181e4629f","article-title":"From human papillomavirus to cervical cancer","volume":"116","author":"Schiffman","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0185","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0190","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0195","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","article-title":"A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States","volume":"17","author":"Insinga","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0200","series-title":"New Developments in Cervical Screening and Prevention","article-title":"Human papillomavirus testing for primary screening","author":"Meiijer","year":"1997"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.ygyno.2011.04.037_bb0210","first-page":"679","article-title":"Stability of integrated HPV 16 DNA in various sample transport media","volume":"9","author":"Anekella","year":"2007","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0215","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2006.05.033","article-title":"Recovery of human papillomavirus nucleic acids from liquid-based cytology media","volume":"137","author":"Powell","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ygyno.2011.04.037_bb0220","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.22285","article-title":"Human papillomavirus testing using hybrid capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method","volume":"108","author":"Ko","year":"2006","journal-title":"Cancer Cytopathol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811003386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811003386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T04:43:19Z","timestamp":1637728999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811003386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0090825811003386"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.04.037","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}